XGN

Exagen Inc.

XGN | $1.78 -1.66% -1.69% 16K

(0.0% 1d) (15.7% 1m) (-20.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-31.6% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 30,341,572
http://www.exagen.com
Sec Filling | Patents | 156 employees

(US) Exagen, Inc. is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand. Exagen was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

autoimmunity optical brands diagnostics

add to watch list email alert is off

Press-releases

Exagen Inc. Reports Strong Third Quarter 2023 Results
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
results

Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
lupus license biomarkers agreement

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
services health diagnostics

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
Published: 2023-10-30 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
financial results

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
Published: 2023-09-28 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| -24.9% | O: -0.82% H: 4.53% C: -0.41%
meeting

Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-12 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
conference global

Exagen Inc. Reports Strong Second Quarter 2023 Results
Published: 2023-08-07 (Crawled : 12:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| -25.2% | O: 2.85% H: 0.0% C: 0.0%
results

Immunodiagnostics Market size to grow by USD 22,669.75 million from 2022 to 2027|Increased demand for biomarker-based tests boost the market - Technavio
Published: 2023-07-28 (Crawled : 23:00) - prnewswire.com
TMO | News | $491.6 -0.76% 0.0% 1.6M

Health Technology

| Email alert Add to watchlist
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| Email alert Add to watchlist
ABT | News | $104.35 -0.8% 0.0% 4.3M

Health Technology

| Email alert Add to watchlist
market

Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services

| -23.33% | O: -3.75% H: 4.33% C: 1.73%
conference growth

Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
Published: 2023-07-25 (Crawled : 20:00) - globenewswire.com
XGN | $1.78 -1.66% -1.69% 16K

Health Services